0000899243-16-022931.txt : 20160615
0000899243-16-022931.hdr.sgml : 20160615
20160615161521
ACCESSION NUMBER: 0000899243-16-022931
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160614
FILED AS OF DATE: 20160615
DATE AS OF CHANGE: 20160615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freed Martin I
CENTRAL INDEX KEY: 0001676653
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 161715437
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-14
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001676653
Freed Martin I
C/O DICERNA PHARMACEUTICALS, INC.
87 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
1
0
0
0
Employee Stock Option (Right to Buy)
3.26
2016-06-14
4
A
0
25000
0.00
A
2026-06-14
Common Stock
25000
25000
D
The option vests as to one-third of the underlying shares on June 14, 2017 and as to the remaining two-thirds of the shares in eight quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each such date.
/s/ Michael Todisco, attorney-in-fact
2016-06-15